Le Lézard
Classified in: Health, Science and technology
Subject: Product/Service

ReadCoor, Inc. Unveils True Spatial Sequencing Platform to Drive Groundbreaking Insights into Immuno-oncology, Neuroscience, and Infectious Disease


ReadCoor, Inc., a company leading true multi-omic spatial sequencing, today unveils its first product line, including multi-omic spatial sequencing assays and the RC2 instrument. The platform is powered by ReadCoor's proprietary FISSEQ (Fluorescent in situ Sequencing) technology, which combines the massive multiplexity of next-generation sequencing (NGS) and high-resolution tissue imaging. The fully integrated platform is now available for use by researchers through ReadCoor's Select Release Program (SRP), focusing on initial applications in immuno-oncology, neuroscience, and infectious disease, as well as a custom offering. ReadCoor has increased its Series B investment round to $30 million to accelerate commercial efforts.

The new platform simultaneously detects tens to thousands of RNA and DNA sequences, proteins, and therapeutic molecules at nanoscale 3D resolution in every cell within an intact tissue sample. The key products launched today are:

"We firmly believe our true multi-omic sequencing technology will have a dramatic impact on medicine and healthcare, and this motivates us to provide researchers products that offer unprecedented and meaningful insights into human biology," said Richard Terry, Chief Executive Officer, Chief Technical Officer, and Founder of ReadCoor. "Our Select Release Program serves as the foundation for researchers to develop new therapeutics and treatments to ultimately improve patient care."

Users within the SRP can use ReadCoor's initial applications to support their specific research interests. The applications offer the following capabilities:

About ReadCoor, Inc.

ReadCoor is a technology company offering the first true spatial multi-omic platform to the global audience of researchers, clinicians, pharma and diagnostics companies to expand understanding of human biology and facilitate the creation of new therapeutics for patients. The company's RC2 platform simultaneously detects and reads the sequences of tens to thousands of RNA, DNA, proteins and therapeutics and visualizes sub-cellular nanoscale 3D resolution in every cell throughout any tissue section. The platform is based on ReadCoor's proprietary Fluorescent in situ Sequencing (FISSEQ) technology, which combines the massive multiplexity of next generation sequencing (NGS) and high-resolution tissue imaging. Learn more at www.readcoor.com.


These press releases may also interest you

at 10:17
Pasternack, an Infinite Electronics brand and a leading provider of RF, microwave and millimeter-wave products, has announced the launch of its new trihedral corner reflectors. These reflectors, featuring a unique trihedral design, are poised to...

at 10:15
The wireless testing market is projected to grow from USD 22.6 billion in 2024 to USD 34.1 billion by 2029, registering a CAGR of 8.6% during the forecast period according to a new report by MarketsandMarketstm. The market growth is attributed to...

at 10:15
Chartis, a comprehensive healthcare advisory firm, today announced that its line of business focused on helping medical staff services departments (MSSDs) transform to elevate performance will restore its former name?Greeley, A Chartis Company. It...

at 10:15
A report from Hainan International Media Center (HIMC):  Reporters attending the Boao Forum for Asia (BFA) Annual Conference 2024 were impressed by the Boao Near-Zero Carbon Demonstration Zone when visiting the computer room of the BFA Hotel on Mar....

at 10:14
ElementalTV, an innovator of data-enriched CTV advertising audience solutions, has announced a strategic partnership with Spanglish Movies, a leader in content creation and publishing for the Hispanic market. Together, the companies have created...

at 10:10
A new market study of 2,008 adults in the U.S. and U.K. reveals 83% of consumers want brands to use video more to communicate with them, but 64% rarely or never get video communications. The State of Video Technology report released today also...



News published on and distributed by: